← Back to patent-cliff list
CAS 144490-03-9
(2R,3S,4S,5S)-5-(acetoxymethyl)tetrahydrofuran-2,3,4-triyl triacetate
Codes: MARI-002
Application context (from source-drug indications)
巨细胞病毒感染MaribavirHaematological malignancyMaribavirHIV infectionMaribavir
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Maribavir | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-bromo-5,6-dichloro-1H-benzo[d]imidazole→(2R,3S,4S,5S)-5-(acetoxymethyl)tetrahydrofuran-2,3,4-triyl triacetate→(2S,3S,4S,5S)-2-(acetoxymethyl)-5-(2-bromo-5,6-dichloro-1H-benzo[d]imidazol-1-yl)tetrahydrofuran-3,4-diyl diacetate
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Qualified Partner — East China API Works | 1,2,3,5-TETRA-O-ACETYL-BETA-L-RIBOFURANOSE Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.